The Nasdaq Stock Market ended the session with Arena Pharmaceuticals jumping 3.78% to $69.27 on Tuesday while the Nasdaq Stock Market rose 0.45% to $12,576.50.

Arena Pharmaceuticals today’s close was $69.27, 30.20% under its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the current quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals’s Stock Top and Bottom Yearly Value

Arena Pharmaceuticals’s stock is valued at $69.27 at 16:17 EST, way under its 52-week high of $90.19 and way above its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is below its 50-day moving average of $73.92 and above its 200-day moving average of $68.94.

LEAVE A REPLY

Please enter your comment!
Please enter your name here